Effectiveness and Safety of Topical Finasteride for Male Androgenetic Alopecia: Real World Data - PubMed
3 hours ago
- #topical finasteride
- #hair loss treatment
- #androgenetic alopecia
- Topical finasteride 0.25% monotherapy was evaluated for 52 weeks in 146 men with androgenetic alopecia (AGA).
- Significant increases in target area hair count (TAHC) were observed at both vertex (+22.7 hairs/cm²) and frontotemporal regions (+32.3 hairs/cm²).
- Improvements in target area hair width (TAHW) and terminal-to-vellus hair ratio were also noted in both regions.
- Patient-reported outcomes (MHGQ score: 14.7 ± 2.9) and physician evaluations (PGA: +1.9 ± 0.8) indicated positive results.
- Mild, transient local irritation occurred in 6.2% of patients, with no systemic adverse effects reported.
- The study supports topical finasteride as an effective and safe long-term treatment for male AGA, particularly in frontotemporal regions.